Chu Steven 4
4 · Zymergen Inc. · Filed Oct 19, 2022
Insider Transaction Report
Form 4
Chu Steven
Director
Transactions
- Disposition to Issuer
Stock Options
2022-10-19−33,333→ 0 totalExercise: $10.35Exp: 2020-12-16→ Common Stock (33,333 underlying) - Disposition to Issuer
Stock Options
2022-10-19−132,333→ 0 totalExercise: $2.70Exp: 2026-06-24→ Common Stock (132,333 underlying) - Disposition to Issuer
Common Stock
2022-10-19−50,000→ 0 total
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022 (the "Merger Agreement"), by and among Ginkgo Bioworks Holdings, Inc. ("Ginkgo"), Pepper Merger Subsidiary Inc. and the Issuer, each share of the Issuer's common stock was cancelled and converted into a right to receive 0.9179 of a share of Class A common stock of Ginkgo (the "Merger Consideration"), together with cash in lieu of any fractional shares of Class A common stock of Ginkgo. Immediately prior to the effective time of the merger (the "Effective Time"), all outstanding Issuer restricted stock units ("RSUs") vested in full pursuant to the terms of the agreements governing such Issuer RSUs. Pursuant to the Merger Agreement, immediately prior to the Effective Time, the Issuer RSUs were cancelled and converted into a right to receive the Merger Consideration in respect of such Issuer RSUs and cash in lieu of any fractional shares of Class A common stock of Ginkgo.
- [F2]Immediately prior to the Effective Time, all outstanding Issuer stock options vested in full pursuant to the terms of the agreements governing such stock options. Pursuant to the Merger Agreement, at the Effective Time, each Issuer stock option with an exercise price per share equal to or greater than the Merger Consideration Value (as defined in the Merger Agreement) was cancelled for no consideration.